OTC Ear Care Firm Eosera Gets Earful From US FDA On Pain And Itch Remedies, GMP Compliance
Eosera has removed its Ear Pain MD and Ear Itch MD products from e-commerce pages on its website following FDA's warning letter. The warning identifying the pain and itch products as unapproved new drugs also states that a January inspection of the firm’s facility found GMP violations.
You may also be interested in...
Adventure Ready Brands is the second small firm warned recently by FDA about manufacturing and marketing products labeled as nonprescription drugs but noncompliant with relevant OTC drug monographs and about GMP violations.
HBW Market News: VSI Focuses On First Offer, Nestle Invests In Consumer Health, Eosera Adds Products, Space, Staff
Vitamin Shoppe discloses preliminary plan for shareholder vote on $208m takeover offer; Nestle Health Science invests in SpoonfulOne early childhood food allergy prevention brand; and ear care product firm Eosera moves to facility twice as large and adds two products, four staff members.
GT's Living autumn kombucha; Mommez Choice and Eosera expand children's products; ThriveFit from level brands; Herbalife sponsors LA triathlon; Amino4U capsules, powder help patients recover from injuries, surgeries; Designer Protein's whey in Target; HumanN brand adds SuperBeets Immune; and Nutrition 21 ads west coast sales manager.